Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals, and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic versions of Abilify in multiple strengths and dosage forms.
Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder.
“Having access to treatments is important for patients with long-term health conditions,” said John Peters, M.D., Acting Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research.
Schizophrenia is a chronic, severe and disabling brain disorder, while Bipolar disorder, also known as manic-depressive illness, is another brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks.
